Snowball logo
logo
4503_logo

Astellas Pharma Inc.

¥2,327.50-¥28.50  (1.21%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
1,296,1631,518,6191,603,6721,912,3232,139,2452,139,245
COGS
253,009288,353292,485349,206544,408511,641
Gross Profit
1,043,1541,230,2661,311,1871,563,1171,594,8371,627,604
Operating Expenses & Income
Operating Income
220,021285,430178,070255,672419,698404,842
Total Operating Expenses
823,133944,8361,133,1171,307,4451,175,1391,222,762
R&D Expenses
246,000276,100294,200327,700314,827314,827
Selling General & Admin Expenses
548,840630,272740,110843,032860,312-
Earnings from Continuing Operations
Interest Expense
(4,949)(8,779)(9,368)(17,677)(14,072)(14,072)
Interest Income
6,1498,11011,4557,8748,026-
Income Tax Expense
32,80033,6477,924(19,510)85,01385,013
Net Income
Net Income
124,08698,71417,04550,747291,535291,575
Supplemental
EBIT
218,145231,652124,606263,540390,659398,421
EBITDA
297,829337,390282,446462,672585,253593,015
In millions of JPY, except % and values per 1 share